title: Does the availability of a neuraminidase inhibitor impair influenza vaccination? A report from Austria.
authors.forename: U
authors.initials: U
authors.lastname: Kunze
authors.forename: E
authors.initials: E
authors.lastname: Groman
authors.forename: K
authors.initials: K
authors.lastname: Vymazal
authors.forename: H K
authors.initials: HK
authors.lastname: Hartl
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D001317:Austria / Q000453:epidemiology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006146:Guanidines; D006801:Humans; D007252:Influenza Vaccines / Q000494:pharmacology*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D011714:Pyrans; D012794:Sialic Acids / Q000494:pharmacology*; D014611:Vaccination / Q000706:statistics & numerical data; D053243:Zanamivir
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D007252:Influenza Vaccines; D011714:Pyrans; D012794:Sialic Acids; D009439:Neuraminidase; D053243:Zanamivir